Jessica Schmidt

2.4k total citations · 1 hit paper
22 papers, 1.6k citations indexed

About

Jessica Schmidt is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jessica Schmidt has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Hematology and 3 papers in Oncology. Recurrent topics in Jessica Schmidt's work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (14 papers) and Ubiquitin and proteasome pathways (7 papers). Jessica Schmidt is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (14 papers) and Ubiquitin and proteasome pathways (7 papers). Jessica Schmidt collaborates with scholars based in United States, Canada and India. Jessica Schmidt's co-authors include A. Keith Stewart, Esteban Braggio, P. Leif Bergsagel, Chang-Xin Shi, Rafaël Fonseca, Yuan Xiao Zhu, Laura A. Bruins, Xiu-Bao Chang, Rodger E. Tiedemann and Robert Z. Orlowski and has published in prestigious journals such as Journal of the American Chemical Society, Blood and PLoS ONE.

In The Last Decade

Jessica Schmidt

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

2011 461 citations Yuan Xiao Zhu, Esteban Braggio et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jessica Schmidt United States	14	1.4k	1.0k	477	132	126	22	1.6k
Yuan Xiao Zhu United States	19	1.4k 1.0×	945 0.9×	494 1.0×	142 1.1×	108 0.9×	47	1.8k
Patricia Gomez‐Bougie France	22	1.0k 0.8×	463 0.5×	395 0.8×	182 1.4×	146 1.2×	38	1.3k
Yi Hua Qiu United States	18	974 0.7×	633 0.6×	236 0.5×	103 0.8×	163 1.3×	38	1.4k
Sarah J. Neering United States	7	1.3k 1.0×	928 0.9×	414 0.9×	33 0.3×	191 1.5×	12	1.9k
Simona Blotta United States	12	663 0.5×	298 0.3×	452 0.9×	71 0.5×	38 0.3×	22	1.0k
Géraldine Descamps France	20	731 0.5×	429 0.4×	350 0.7×	116 0.9×	78 0.6×	30	1.1k
Boris Kovačic Austria	17	463 0.3×	461 0.5×	692 1.5×	116 0.9×	354 2.8×	25	1.4k
Margaret Nieborowska-Skorska United States	23	1.1k 0.8×	1.2k 1.2×	478 1.0×	140 1.1×	705 5.6×	54	2.1k
Paul M. Ayton United States	15	2.1k 1.5×	1.2k 1.2×	483 1.0×	62 0.5×	184 1.5×	17	2.6k
Bangzheng Chen United States	6	584 0.4×	430 0.4×	320 0.7×	114 0.9×	62 0.5×	8	900

Countries citing papers authored by Jessica Schmidt

Since Specialization

Citations

This map shows the geographic impact of Jessica Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Schmidt more than expected).

Fields of papers citing papers by Jessica Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Schmidt. The network helps show where Jessica Schmidt may publish in the future.

Co-authorship network of co-authors of Jessica Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Schmidt. A scholar is included among the top collaborators of Jessica Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Schmidt. Jessica Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Costello, Collin M., Jessica Schmidt, Richard Butterfield, et al.. (2019). Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. 82(4). 846–853. 13 indexed citations

Costello, Collin M., Nan Zhang, Richard Butterfield, et al.. (2018). The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. 80(3). 626–632.e1. 14 indexed citations

Kang, Hyun-Jin, Yunxi Cui, Holly Yin, et al.. (2016). A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters. Journal of the American Chemical Society. 138(41). 13673–13692. 79 indexed citations

Egan, Jan B., Michael T. Barrett, Mia D. Champion, et al.. (2014). Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements. PLoS ONE. 9(2). e87113–e87113. 15 indexed citations

Zhu, Yuan Xiao, Hongwei Yin, Laura A. Bruins, et al.. (2014). RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125(3). 483–491. 18 indexed citations

Zhu, Yuan Xiao, Esteban Braggio, Chang-Xin Shi, et al.. (2014). Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood. 124(4). 536–545. 170 indexed citations

Schuster, Steven R., K. Martin Kortuem, Yuan Xiao Zhu, et al.. (2013). The clinical significance of cereblon expression in multiple myeloma. Leukemia Research. 38(1). 23–28. 85 indexed citations

Schmidt, Jessica, Esteban Braggio, K. Martin Kortuem, et al.. (2013). Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Leukemia. 27(12). 2357–2365. 122 indexed citations

Egan, Jan B., Chang-Xin Shi, Waibhav Tembe, et al.. (2012). Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 120(5). 1060–1066. 286 indexed citations

10.

Schmidt, Jessica, Esteban Braggio, Marta Chesi, et al.. (2012). Genome Wide Studies in Multiple Myeloma Identify XPO1/CRM-1 As a Critical Target Validated Using the Selective Inhibitor of Nuclear Export (SINE) KPT-276. Blood. 120(21). 573–573. 2 indexed citations

11.

Schuster, Steven R., K. Martin Kortuem, Yuan Xiao Zhu, et al.. (2012). Cereblon Expression Predicts Response, Progression Free and Overall Survival After Pomalidomide and Dexamethasone Therapy in Multiple Myeloma. Blood. 120(21). 194–194. 12 indexed citations

12.

Zhu, Yuan Xiao, Chang‐Xin Shi, Laura A. Bruins, et al.. (2012). Cereblon Binding IMiD Small Molecules Mediate Myeloma Cell Death Via IRF4. Blood. 120(21). 1807–1807. 1 indexed citations

13.

Tiedemann, Rodger E., Jessica Schmidt, Shi Chang, et al.. (2011). Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome. Cancer Research. 72(3). 757–768. 107 indexed citations

14.

Zhu, Yuan Xiao, Rodger E. Tiedemann, Chang-Xin Shi, et al.. (2011). RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5. Blood. 117(14). 3847–3857. 81 indexed citations

15.

Zhu, Yuan Xiao, Esteban Braggio, Jessica Schmidt, et al.. (2011). Cereblon Expression Is Required for the Anti-Myeloma Activity of Lenalidomide and Pomalidomide. Blood. 118(21). 127–127. 14 indexed citations

16.

Zhu, Yuan Xiao, Esteban Braggio, Chang-Xin Shi, et al.. (2011). Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide. Blood. 118(18). 4771–4779. 461 indexed citations breakdown →

17.

Tiedemann, Rodger E., Yuan Xiao Zhu, Jessica Schmidt, et al.. (2009). Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. Blood. 115(8). 1594–1604. 83 indexed citations

18.

Zhu, Yuan Xiao, Rodger E. Tiedemann, Jessica Schmidt, et al.. (2009). RNAi Screen of the Druggable Genome Identifies Modulators of Proteasome Inhibitor Sensitivity in Myeloma Including CDK5.. Blood. 114(22). 602–602. 1 indexed citations

19.

Tiedemann, Rodger E., Yuan Xiao Zhu, Jessica Schmidt, et al.. (2009). Achilles Heel Molecular Vulnerabilities in Multiple Myeloma Identified From Genome-Scale RNA Interference Screening.. Blood. 114(22). 2801–2801. 1 indexed citations

20.

Tiedemann, Rodger E., Jessica Schmidt, Jonathan J. Keats, et al.. (2008). Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo. Blood. 113(17). 4027–4037. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact